癌症中的自:依赖于环境的调节和精确的纳米医学支持的治疗向
Yuzhi Lu1, Ang Li2, Andong Liu2
1Department of Respiratory and Critical Care Medicine, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Biomedicines
|February 27, 2026
概括
自,一个细胞过程,在癌症中起着双重作用,抑制早期瘤,但有助于癌症的晚期进展. 针对自需要考虑瘤微环境,以有效治疗癌症.
科学领域:
- 细胞生物学 细胞生物学
- 癌症研究 癌症研究
- 分子瘤学分子瘤学
背景情况:
- 自是一种基本的细胞降解途径,对恒常状态至关重要.
- 它在癌症中的作用是复杂的,在早期起到瘤抑制作用,但在晚期促进进展,治疗耐药性和免疫逃避.
- 这种双重性使治疗策略复杂化,原因是自调节中的时空异质性.
研究的目的:
- 审查癌症中自调节者的上下文依赖作用.
- 分析瘤阶段,遗传学和瘤微环境 (TME) 如何影响自.
- 建议在癌症治疗中针对情境感知自的框架.
主要方法:
- 对关键的自调节器进行系统检查 (贝克林-1,p62/SQSTM1,mTOR,p53).
- 调节因素的分析,包括瘤阶段,遗传背景和微环境线索 (低氧,免疫压力,树皮相互作用).
- 讨论基于纳米技术的传递系统,用于控制的自调节.
主要成果:
- 自调节器的功能是作为上下文依赖的治疗节点,而不是通用目标.
- 在TME批判性地决定了自性依赖和治疗脆弱性.
- 微环境无意识的自调节导致不一致的结果.
- 纳米技术为自调节提供了精确的空间和时间控制.
结论:
- 提出了一个整合分子分析,TME特征和纳米医学的框架,用于利用癌症中的自性.
- 在开发有效和个性化的癌症治疗中,对自的上下文意识的向至关重要.
- 了解瘤微环境是克服自性向癌症治疗挑战的关键.
相关概念视频
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
03:03mTOR Signaling and Cancer Progression
4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.9K
01:27Autophagy
6.0K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
6.0K
01:36Delivery Pathways to the Lysosome
10.4K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
10.4K
02:50Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
01:18Autophagic Cell Death
4.8K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.8K